India expected to have Covid vaccine by early next year: Health minister

Vardhan had earlier said a Covid-19 vaccine is likely to be available by the first quarter of 2021

Harsh Vardhan
File Photo of Health Minister Dr Harsh Vardhan
Press Trust of India
2 min read Last Updated : Oct 13 2020 | 11:54 PM IST
India is expected to have a Covid-19 vaccine from more than one source by early next year and the government is formulating distribution strategies for the immunisation of people across the country, Union Health Minister Harsh Vardhan said on Tuesday.

"We're expecting that early next year we should have vaccine in the country from more than one source.

"We are formulating strategies for planned distribution of the vaccine in the country," he said in a tweet after chairing the 21st meeting of the high-level Group of Ministers (GoM) on Covid-19 through video-conference.

Vardhan had earlier said a Covid-19 vaccine is likely to be available by the first quarter of 2021. He had also said the Centre estimates to receive and utilise 40-50 crore doses of a Covid-19 vaccine, covering 20-25 crore people, by July next year.

On Sunday, the minister said considering the large population size of India, one vaccine or vaccine manufacturer will not be able to fulfil the requirements of vaccinating the entire country and added that the government is open to assessing the feasibility of introducing several Covid-19 vaccines in the country in accordance with their availability.

Vardhan further said the country's preparedness to make a Covid-19 vaccine available to its citizens was reviewed at the GoM meet.

He added that work is going on around 200 vaccine candidates across the world, of which 151 are in pre-clinical stages and about 40-42 are in various clinical trial stages. Nine vaccine candidates are in an advanced clinical trial stage, of which three are in India.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus VaccineHarsh Vardhan

Next Story